GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » ROCE %

Pulike Biological Engineering (SHSE:603566) ROCE % : 4.62% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pulike Biological Engineering's annualized ROCE % for the quarter that ended in Mar. 2024 was 4.62%.


Pulike Biological Engineering ROCE % Historical Data

The historical data trend for Pulike Biological Engineering's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulike Biological Engineering ROCE % Chart

Pulike Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.99 15.16 15.32 7.66 6.99

Pulike Biological Engineering Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.61 7.89 9.58 -0.62 4.62

Pulike Biological Engineering ROCE % Calculation

Pulike Biological Engineering's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=195.535/( ( (3395.53 - 556.134) + (3262.209 - 508.029) )/ 2 )
=195.535/( (2839.396+2754.18)/ 2 )
=195.535/2796.788
=6.99 %

Pulike Biological Engineering's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=127.656/( ( (3262.209 - 508.029) + (3205.137 - 436.327) )/ 2 )
=127.656/( ( 2754.18 + 2768.81 )/ 2 )
=127.656/2761.495
=4.62 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pulike Biological Engineering  (SHSE:603566) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Pulike Biological Engineering ROCE % Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering (SHSE:603566) Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines